Evidence map›Paper›PMID 38324353›Full record

ArticleJournal of cell science2024

Harnessing artificial intelligence to reduce phototoxicity in live imaging.

Estibaliz Gómez-de-Mariscal, Mario Del Rosario, Joanna W Pylvänäinen, Guillaume Jacquemet, Ricardo Henriques

Abstract read
In one paragraph

Article in Journal of cell science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Estibaliz Gómez-de-MariscalInstituto Gulbenkian de Ciência, Oeiras 2780-156, Portugal.ORCID 0000-0003-2082-3277
Mario Del RosarioInstituto Gulbenkian de Ciência, Oeiras 2780-156, Portugal.ORCID 0000-0002-0430-1463
Joanna W PylvänäinenFaculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku 20500, Finland.
Guillaume JacquemetFaculty of Science and Engineering, Cell Biology, Åbo Akademi University, Turku 20500, Finland.ORCID 0000-0002-9286-920X
Ricardo HenriquesInstituto Gulbenkian de Ciência, Oeiras 2780-156, Portugal.ORCID 0000-0002-2043-5234

Funding

European Research Council
6 · The paper itself

Abstract

Fluorescence microscopy is essential for studying living cells, tissues and organisms. However, the fluorescent light that switches on fluorescent molecules also harms the samples, jeopardizing the validity of results - particularly in techniques such as super-resolution microscopy, which demands extended illumination. Artificial intelligence (AI)-enabled software capable of denoising, image restoration, temporal interpolation or cross-modal style transfer has great potential to rescue live imaging data and limit photodamage. Yet we believe the focus should be on maintaining light-induced damage at levels that preserve natural cell behaviour. In this Opinion piece, we argue that a shift in role for AIs is needed - AI should be used to extract rich insights from gentle imaging rather than recover compromised data from harsh illumination. Although AI can enhance imaging, our ultimate goal should be to uncover biological truths, not just retrieve data. It is essential to prioritize minimizing photodamage over merely pushing technical limits. Our approach is aimed towards gentle acquisition and observation of undisturbed living systems, aligning with the essence of live-cell fluorescence microscopy.

Indexed as

Artificial IntelligenceSoftwareMicroscopy, FluorescenceArtificial intelligenceData-driven microscopyDeep learningFluorescence microscopyLive-cell super-resolution microscopyLive-microscopyPhotodamagePhototoxicity

Identifiers

PMID38324353
PMCPMC10912813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.